Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Inés Velazquez-Quesada"'
Autor:
Kim S. Midwood, Gertraud Orend, Zhen Sun, Imogen Mazzier, Inés Velazquez-Quesada, Nicodème Paul, Raphael Carapito, Anna M. Marzeda, Thomas Loustau, William Erne, Martha Gschwandtner, Anís N. Gammage, Devadarssen Murdamoothoo, Claire Deligne
The interplay between cancer cells and immune cells is a key determinant of tumor survival. Here, we uncovered how tumors exploit the immunomodulatory properties of the extracellular matrix to create a microenvironment that enables their escape from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1733f41e57eae86345e7ba64809d5b5e
https://doi.org/10.1158/2326-6066.c.6550338.v1
https://doi.org/10.1158/2326-6066.c.6550338.v1
Autor:
Kim S. Midwood, Gertraud Orend, Zhen Sun, Imogen Mazzier, Inés Velazquez-Quesada, Nicodème Paul, Raphael Carapito, Anna M. Marzeda, Thomas Loustau, William Erne, Martha Gschwandtner, Anís N. Gammage, Devadarssen Murdamoothoo, Claire Deligne
Supplementary figures and table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697242ea3186c59ca7b6a72d7b9e790f
https://doi.org/10.1158/2326-6066.22543632
https://doi.org/10.1158/2326-6066.22543632
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
Autor:
Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz, Gilles Riegel, Chérine Abou‐Faycal, Claire Deligne, Ines Velazquez‐Quesada, William Erne, Marine Nascimento, Matthias Mörgelin, Gérard Cremel, Nicodème Paul, Raphael Carapito, Romain Veber, Hélène Dumortier, Jingping Yuan, Kim S Midwood, Thomas Loustau, Gertraud Orend
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 6, Pp 1-21 (2021)
Abstract Immune checkpoint therapy, where CD8 tumor infiltrating T lymphocytes (TIL) are reactivated, is a promising anti‐cancer treatment approach, yet with low response rates. The extracellular matrix, in particular tenascin‐C, may generate bar
Externí odkaz:
https://doaj.org/article/b3b3bbcf9e5c4240a68764406229c8d2
Autor:
Alexia Arpel, Paul Sawma, Caroline Spenlé, Justine Fritz, Lionel Meyer, Norbert Garnier, Inés Velázquez-Quesada, Thomas Hussenet, Samia Aci-Sèche, Nadège Baumlin, Monique Genest, David Brasse, Pierre Hubert, Gérard Crémel, Gertraud Orend, Patrice Laquerrière, Dominique Bagnard
Publikováno v:
Cell Reports, Vol 8, Iss 6, Pp 1714-1721 (2014)
Breast cancer is still a deadly disease despite major achievements in targeted therapies designed to block ligands or ligand-binding subunits of major tyrosine kinase receptors. Relapse is significant and metastases deleterious, which demands novel s
Externí odkaz:
https://doaj.org/article/5035aef430b144c08f074fa6ec612cbd